ArticleAmerican journal of cancer research2022

Ipatasertib, an oral AKT inhibitor, inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancer.

Lindsey Buckingham et al.PubMed ↗Full text ↗

No numbers read from the abstract.